Company Filing History:
Years Active: 1999
Title: Inventor Spotlight: Demitris Savva
Introduction
Demitris Savva is a notable inventor based in Reading, GB, who has made significant contributions to the field of biotechnology. With a focus on enzymatic research, he has been instrumental in developing innovations that leverage biological systems for practical applications.
Latest Patents
Demitris is credited with one patent, which concerns an enzyme exhibiting B-1,3-glucanase activity. The patent details a DNA construct that includes expression vectors and cells that harbor the DNA construct or expression vector. Additionally, it outlines methods for producing the enzyme, alongside the enzyme itself and various preparations containing it.
Career Highlights
Currently, Demitris is employed at Novo Nordisk A/S, a global leader in diabetes care and other serious chronic conditions. His work at the company contributes to advancements in enzyme-based technologies, emphasizing his role in driving innovation within the biotechnology sector.
Collaborations
Demitris collaborates closely with fellow researchers Pau Ferrer and Ivan Verner Diers. Their collective expertise enhances the development of biotechnological solutions and fosters a dynamic research environment within their organization.
Conclusion
Demitris Savva’s work exemplifies the spirit of innovation, demonstrating how a single patent can pave the way for future advancements in biotechnology. His contributions, alongside his collaborations, continue to impact the industry and inspire upcoming inventors.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.